These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

824 related articles for article (PubMed ID: 23442774)

  • 21. Diagnostic value of Gd-EOB-DTPA-enhanced MR cholangiography in non-invasive detection of postoperative bile leakage.
    Kul M; Erden A; Düşünceli Atman E
    Br J Radiol; 2017 Apr; 90(1072):20160847. PubMed ID: 28181823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gd-EOB-DTPA enhanced MRI for hepatocellular carcinoma: quantitative evaluation of tumor enhancement in hepatobiliary phase.
    Saito K; Kotake F; Ito N; Ozuki T; Mikami R; Abe K; Shimazaki Y
    Magn Reson Med Sci; 2005; 4(1):1-9. PubMed ID: 16127248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and validation of a predictor of insufficient enhancement during the hepatobiliary phase of Gd-EOB-DTPA-enhanced magnetic resonance imaging.
    Cui E; Long W; Luo L; Hu M; Huang L; Chen X
    Acta Radiol; 2017 Oct; 58(10):1174-1181. PubMed ID: 28090793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Features of acute liver congestion on gadoxetate disodium-enhanced MRI in a rat model: Role of organic anion-transporting polypeptide 1A1.
    Shimizu A; Kobayashi A; Motoyama H; Sakai H; Yamada A; Yoshizawa A; Momose M; Kadoya M; Miyagawa S
    J Magn Reson Imaging; 2015 Sep; 42(3):828-36. PubMed ID: 25581836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased hepatic and renal expressions of multidrug resistance-associated protein 3 in Eisai hyperbilirubinuria rats.
    Kuroda M; Kobayashi Y; Tanaka Y; Itani T; Mifuji R; Araki J; Kaito M; Adachi Y
    J Gastroenterol Hepatol; 2004 Feb; 19(2):146-53. PubMed ID: 14731123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can the biliary enhancement of Gd-EOB-DTPA predict the degree of liver function?
    Okada M; Ishii K; Numata K; Hyodo T; Kumano S; Kitano M; Kudo M; Murakami T
    Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):307-13. PubMed ID: 22672826
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial.
    Zech CJ; Grazioli L; Breuer J; Reiser MF; Schoenberg SO
    Invest Radiol; 2008 Jul; 43(7):504-11. PubMed ID: 18580333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phantom and animal studies of a new hepatobiliary agent for MR imaging: comparison of Gd-DTPA-DeA with Gd-EOB-DTPA.
    Yoshikawa K; Inoue Y; Akahane M; Shimada M; Itoh S; Seno A; Hayashi S
    J Magn Reson Imaging; 2003 Aug; 18(2):204-9. PubMed ID: 12884333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multivariable analysis of clinical influence factors on liver enhancement of Gd-EOB-DTPA-enhanced 3T MRI.
    Verloh N; Haimerl M; Zeman F; Teufel A; Lang S; Stroszczynski C; Fellner C; Wiggermann P
    Rofo; 2015 Jan; 187(1):29-35. PubMed ID: 25531338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential of Gd-EOB-DTPA as an imaging biomarker for liver injury estimation after radiation therapy.
    Sun XL; Jiang X; Kuang Y; Xing L; Bu LY; Yuan SH; Yu JM; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):354-359. PubMed ID: 31221569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential clinical factors affecting hepatobiliary enhancement at Gd-EOB-DTPA-enhanced MR imaging.
    Higaki A; Tamada T; Sone T; Kanki A; Sato T; Tanimoto D; Higashi H; Ito K
    Magn Reson Imaging; 2012 Jun; 30(5):689-93. PubMed ID: 22459437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing liver function using dynamic Gd-EOB-DTPA-enhanced MRI with a standard 5-phase imaging protocol.
    Saito K; Ledsam J; Sourbron S; Otaka J; Araki Y; Akata S; Tokuuye K
    J Magn Reson Imaging; 2013 May; 37(5):1109-14. PubMed ID: 23086736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of hepatobiliary uptake of Gd-EOB-DTPA on the hepatic venous phase of dynamic magnetic resonance imaging on a 3.0-T apparatus: comparison between Gd-EOB-DTPA and Gd-DTPA.
    Fujinaga Y; Ohya A; Matsushita T; Kurozumi M; Ueda K; Kitou Y; Ueda H; Kadoya M
    Jpn J Radiol; 2011 Dec; 29(10):695-700. PubMed ID: 22009420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced magnetic resonance imaging for evaluating fibrosis regression in chronic hepatitis C patients after direct-acting antiviral.
    Li XH; Huang R; Yang M; Wang J; Gao YH; Jin Q; Ma DL; Wei L; Rao HY
    World J Gastroenterol; 2022 May; 28(20):2214-2226. PubMed ID: 35721884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of liver fibrosis using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance.
    Sheng RF; Wang HQ; Yang L; Jin KP; Xie YH; Fu CX; Zeng MS
    Dig Liver Dis; 2017 Jul; 49(7):789-795. PubMed ID: 28237298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced MR finding of radiation-induced hepatic injury: relationship to absorbed dose and time course after irradiation.
    Okamoto D; Nishie A; Asayama Y; Tajima T; Ishigami K; Kakihara D; Nakayama T; Ohga S; Yoshitake T; Shioyama Y; Honda H
    Magn Reson Imaging; 2014 Jul; 32(6):660-4. PubMed ID: 24666574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transporters.
    Leonhardt M; Keiser M; Oswald S; Kühn J; Jia J; Grube M; Kroemer HK; Siegmund W; Weitschies W
    Drug Metab Dispos; 2010 Jul; 38(7):1024-8. PubMed ID: 20406852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular enhancement in early dynamic liver MR imaging in an animal model: comparison of two injection regimen and two different doses Gd-EOB-DTPA (gadoxetic acid) with standard Gd-DTPA.
    Zech CJ; Vos B; Nordell A; Urich M; Blomqvist L; Breuer J; Reiser MF; Weinmann HJ
    Invest Radiol; 2009 Jun; 44(6):305-10. PubMed ID: 19462484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intra-individual comparison of different gadolinium-based contrast agents in the quantitative evaluation of C6 glioma with dynamic contrast-enhanced magnetic resonance imaging.
    Li Y; Liu G; Lou X; Chen Z; Ma L
    Sci China Life Sci; 2017 Jan; 60(1):11-15. PubMed ID: 28078511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cirrhotic rat liver: reference to transporter activity and morphologic changes in bile canaliculi--gadoxetic acid-enhanced MR imaging.
    Tsuda N; Matsui O
    Radiology; 2010 Sep; 256(3):767-73. PubMed ID: 20663976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.